Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations

Frontiers in Cell and Developmental Biology(2023)10.3389/fcell.2023.1254313Source: DataRank Database

Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations is a research paper published in Frontiers in Cell and Developmental Biology (2023). On theSindex it has a DataRank of 0. It has been cited 38 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access38 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 4.11)OA: goldTopics (26)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Karen Wang,Gloria V. Echeverria ORCID,Katherine E. Pendleton ORCID

Live enrichment

PubMed:37779896 PMC:PMC10534013 OpenAlex:https://openalex.org/W4386699775

NCI NIH HHS

Grant: R37 CA269783

NCI NIH HHS

Grant: F31 CA275397

NIGMS NIH HHS

Grant: T32 GM139534

National Institutes of Health

Grant: 5R37CA269783-03

Metabolic adaptation in residual triple negative breast cancer following chemotherapy

National Institutes of Health

Grant: 5T32GM139534-04

Genetics & Genomics Training Program

National Institutes of Health

Grant: 1F31CA275397-01

Investigating the role of CRAT as a driver of triple negative breast cancer chemoresistance

American Cancer Society

Cancer Prevention and Research Institute of Texas

National Institutes of Health

National Cancer Institute

FWCI

4.11

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fcell.2023.1254313/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fcell.2023.1254313/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fcell.2023.1254313/full

journalhttps://doi.org/10.3389/fcell.2023.1254313

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37779896

Fields of Study

Cancer, Hypoxia, and MetabolismHistone Deacetylase Inhibitors ResearchMetabolism, Diabetes, and Cancer03 medical and health sciences0302 clinical medicine

Keywords

MitochondrionBiologyPhenotypeCancer cellCell metabolismCancerBioinformaticsCancer therapyCancer researchCellNeuroscienceCell biologyGeneticsGeneResistanceMetabolismPlasticityOxphos (Oxidative Phosphorylation)Cell and Developmental BiologyQH301-705.5Biology (General)

Sustainable Development Goals

SDG 0: Good health and well-being